YM311 / FibroGen, Astellas  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
YM311 / Astellas, FibroGen
NCT00456053: A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin

Completed
2
145
US
FG2216
FibroGen
Renal Anemia
 
07/07

Download Options